about
Emerging treatment options for nasopharyngeal carcinomaTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaLabel-retaining cells in the adult murine salivary glands possess characteristics of adult progenitor cellsLong-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Influence of Cervical Node Necrosis of Different Grades on the Prognosis of Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy.Clinicopathologic idiosyncrasies of nasopharyngeal cancer in a moderate-risk Mediterranean region.Current status of cancer care for young patients with nasopharyngeal carcinoma in Jakarta, Indonesia.Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study.Dinitrosopiperazine-mediated phosphorylated-proteins are involved in nasopharyngeal carcinoma metastasis.Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma.The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinomaFeasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer.Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma CellsSustained improvement of quality of life for nasopharyngeal carcinoma treated by intensity modulated radiation therapy in long-term survivors.Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases.The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinomaPrognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma.The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective StudyOverexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinomaInduction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapyEpidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinomaAssociation of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population.Non-invasive detection of nasopharyngeal carcinoma using saliva surface-enhanced Raman spectroscopy.EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRCSurvival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma.Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma.Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas.The tumor shape changes of nasopharyngeal cancer during chemoradiotherapy: the estimated margin to cover the geometrical variation.Dosimetric analysis of isocentrically shielded volumetric modulated arc therapy for locally recurrent nasopharyngeal cancer.
P2860
Q26995560-123126A5-00AA-43F2-8EDF-616F9E8436EFQ27016002-D28C48F4-C9F4-4686-A46C-AFC801C06C75Q27346608-8B906518-1913-4DA3-9ED1-109BD48DC713Q33425830-EFD46FB8-D07D-49C7-A4E1-650D84F17E56Q33435906-825C5441-4D28-4B5A-8B9D-91B461CE118BQ33702308-A07A24F0-0ABD-485E-8A6A-19B4711419E9Q33776991-7F5CE0C4-EEB1-4D92-B2E3-BC857270DE81Q33896645-CE55A0CF-C347-4E32-A0C6-0207EA327929Q34517715-28E0C40C-EB5B-4127-96B8-899D48122349Q34583151-DAF289BC-C05B-4BE2-A114-40818A383734Q34685252-3DE967DC-2C78-4DA7-9504-0EC446BDD861Q34788288-73577194-1534-4EBE-A1F3-71E55C865C1FQ35144019-1E1FB2D9-FEBE-4B05-B70F-B7D02090A592Q35568165-675125AE-D645-43DC-9CA4-525ADA8E4CC4Q35619542-F7E9AE73-4B5C-4874-8008-2A7B73DD9523Q35742407-985CF0CB-8D96-4B1C-B7C2-A50FC8A98F2DQ35750358-1CBEEE04-4F87-4367-8F9F-E6CFDD5FE356Q35791657-1E1447F4-ABAA-4524-9854-2D6980BBEAFCQ35860283-39902A30-F95D-4E00-9984-D9FE70C46772Q35870838-6146E0FE-308D-40E9-88E1-13F580E99259Q35921982-CF8B5313-4A2F-4507-B0D4-67FD8D50F36AQ35955290-1404E7D9-EFF8-4E52-B95A-E5B721E8F6D7Q35974884-5AD3D35A-3E73-4D54-9009-A53D69A62B4BQ36080149-ED8C94A5-27A0-41E0-AD65-7FE8BFD3A5EAQ36081114-E277E09E-C2D4-4420-AEFF-FC0296814F4AQ36117722-444EADC2-279C-495B-B7BA-0D95AF288A87Q36140699-603A9250-CC75-48A7-B3B6-A5672BB5DCE9Q36174879-5EDC7D16-8158-42AF-B602-1E9848FB926BQ36239931-E98B146C-A5AC-433A-86C4-66F404498A12Q36301765-B91BDDFA-0CD1-49C2-8F19-2B4A2FBA2E2EQ36413726-15EEA238-6EEC-4465-BAAF-426D7005F832Q36502753-7511758D-3D84-4CEF-8E9B-B4A7D8E6423FQ36561585-879B94D0-8DBF-4ECA-8729-7E3070416D31Q36618682-F1F5F4C6-6C66-4B00-9729-D3C165AF4CADQ36685565-8A1EC5BE-4B3F-4102-895D-7DF2B9729AE8Q36727111-3895BDDA-5901-4506-81D8-C43CDBBD98A2Q36792351-8BB6C3CE-2223-4A07-92F1-D0B71BC41118Q36859963-9E3053EA-68F2-4291-9758-071FF793CC6EQ36874525-268789D3-DE02-4AAC-AD48-43DA1BAC6AC1Q36897935-8BD07475-92E7-4EBF-B799-2D59D39081A2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current management of nasopharyngeal cancer.
@en
type
label
Current management of nasopharyngeal cancer.
@en
prefLabel
Current management of nasopharyngeal cancer.
@en
P1476
Current management of nasopharyngeal cancer
@en
P2093
Anne W M Lee
P304
P356
10.1016/J.SEMRADONC.2012.03.008
P50
P577
2012-07-01T00:00:00Z